Actrapid and Jaundice - yellow skin - a phase IV clinical study of FDA data

Summary:

Jaundice - yellow skin is reported as a side effect among people who take Actrapid (insulin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Paracetamol, and have Diabetes.

The phase IV clinical study analyzes which people have Jaundice - yellow skin when taking Actrapid. It is created by eHealthMe based on reports of 4,843 people who have side effects when taking Actrapid from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Jaundice - yellow skin?

Jaundice - yellow skin (a yellowish pigmentation of the skin) is found to be associated with 1,466 drugs and 3,046 conditions by eHealthMe. Check the latest studies of Jaundice - yellow skin.

On Jul, 11, 2026

4,843 people reported to have side effects when taking Actrapid.
Among them, 12 people (0.25%) have Jaundice - yellow skin.

Could Actrapid cause Jaundice - yellow skin?

Among these 12 people:

How long have people been on Actrapid when they have Jaundice - yellow skin? *

What is the gender of people who have Jaundice - yellow skin when taking Actrapid? *

female: 80 %
male: 20 %

What is the age of people who have Jaundice - yellow skin when taking Actrapid? *

What are other drugs people take besides Actrapid? *

What are other side effects people have besides Jaundice - yellow skin? *

Hepatic Enzyme Increased: 3 people, 25.00%
Post Procedural Haematoma (post procedural clotting of blood): 2 people, 16.67%
Hypotension (abnormally low blood pressure): 2 people, 16.67%
Duodenal Atresia (absence or complete closure of a portion of the lumen of the duodenum): 2 people, 16.67%
Macrosomia (a condition in which a baby is abnormally large before birth): 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Nausea And Vomiting: 2 people, 16.67%
Gastroschisis (a hole in the abdominal wall): 2 people, 16.67%
Cardiac Disorder: 2 people, 16.67%
Pancreatitis (inflammation of pancreas): 2 people, 16.67%

What are the existing conditions these people have? *

Diabetes: 4 people, 33.33%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Abdominal Pain: 2 people, 16.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
Rectal Tenesmus (a feeling of incomplete defecation): 2 people, 16.67%
Pneumonia: 2 people, 16.67%
Pain: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 2 people, 16.67%
Hypersensitivity: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and have Jaundice - yellow skin?

- Check whether Jaundice - yellow skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actrapid:

Actrapid (4,864 reports)

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (1,466 drugs)

Browse all the conditions that are associated with Jaundice - yellow skin:

Jaundice - yellow skin (3,046 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin (the active ingredients of Actrapid) and Actrapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.